BIOA vs. ORMP

Last updated Aug 1, 2026

BIOA (BioAge Labs, Inc) and ORMP (Oramed Pharmaceuticals Inc.) are both stocks. Both are in the Healthcare sector — BIOA in Drug Manufacturers - Specialty & Generic, ORMP in Biotechnology. Over the past year, BIOA returned 119.42% vs 105.93% for ORMP. Their 0.14 correlation means their historical movements had little consistent relationship.

Performance

BIOA vs. ORMP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in BioAge Labs, Inc (BIOA) and Oramed Pharmaceuticals Inc. (ORMP). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, BIOA achieves a -31.67% return, which is significantly lower than ORMP's 53.19% return.

BIOA

• 1D: -63.62%
• 1M: -63.98%
• 6M: -52.40%
• YTD: -31.67%
• 1Y: 119.42%
• 3Y*: —
• 5Y*: —
• 10Y*: —
• ALL TIME*: -39.04%

ORMP

• 1D: -1.21%
• 1M: -11.52%
• 6M: 20.77%
• YTD: 53.19%
• 1Y: 105.93%
• 3Y*: 9.67%
• 5Y*: -21.00%
• 10Y*: -5.95%
• ALL TIME*: -4.37%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
BIOA BioAge Labs, Inc	$21.91M	$16.92M	$12.89M
ORMP Oramed Pharmaceuticals Inc.	$602.28K	$784.57K	$1.29M

BIOA vs. ORMP - Yearly Performance Comparison

	2026 (YTD)	2025	2024
BIOA BioAge Labs, Inc	-31.67%	128.50%	-74.27%
ORMP Oramed Pharmaceuticals Inc.	53.19%	17.77%	1.26%

Correlation

The correlation between BIOA and ORMP is 0.19, which is low. Their historical price movements had little consistent relationship.

	Correlation
Correlation (1Y) Focuses on recent behavior, but can change the most.	0.19
Correlation (All Time) Calculated using the full available price history since Sep 26, 2024	0.14

Fundamentals

Market Cap BIOA : $340.35M ORMP : $166.57M
EPS BIOA : -$2.36 ORMP : $2.86
PB Ratio BIOA : 1.01 ORMP : 0.72
Total Revenue (TTM) BIOA : $10.32M ORMP : $0.00
Gross Profit (TTM) BIOA : $7.48M ORMP : $0.00
EBITDA (TTM) BIOA : -$95.08M ORMP : $67.00M

Return for Risk

BIOA vs. ORMP — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

BIOA

BIOA Risk / Return Rank: 81
BIOA Sharpe Ratio Rank: 75
BIOA Sortino Ratio Rank: 78
BIOA Omega Ratio Rank: 89
BIOA Calmar Ratio Rank: 75
BIOA Martin Ratio Rank: 85

ORMP

ORMP Risk / Return Rank: 90
ORMP Sharpe Ratio Rank: 91
ORMP Sortino Ratio Rank: 90
ORMP Omega Ratio Rank: 87
ORMP Calmar Ratio Rank: 93
ORMP Martin Ratio Rank: 91

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

BIOA vs. ORMP - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for BioAge Labs, Inc (BIOA) and Oramed Pharmaceuticals Inc. (ORMP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	BIOA	ORMP	Difference
Sharpe ratio: Return per unit of total volatility	1.00	1.92	-0.92
Sortino ratio: Return per unit of downside risk	1.88	2.73	-0.85
Omega ratio: Gain probability vs. loss probability	1.35	1.33	+0.02
Calmar ratio: Return relative to maximum drawdown	1.66	4.34	-2.68
Martin ratio: Return relative to average drawdown	7.25	10.18	-2.94

BIOA vs. ORMP - Sharpe Ratio Comparison

The current BIOA Sharpe Ratio is 1.00, which is lower than the ORMP Sharpe Ratio of 1.92. The chart below compares the historical Sharpe Ratios of BIOA and ORMP, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

BIOA vs. ORMP - Drawdown Comparison

The maximum BIOA drawdown since its inception was -88.23%, smaller than the maximum ORMP drawdown of -94.25%. Use the drawdown chart below to compare losses from any high point for BIOA and ORMP.

Drawdown Indicators

	BIOA	ORMP	Difference
Max Drawdown Largest peak-to-trough decline	-88.23%	-94.25%	+6.02%
Max Drawdown (1Y) Largest decline over 1 year	-63.98%	-23.89%	-40.09%
Max Drawdown (3Y) Largest decline over 3 years	—	-50.29%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-94.25%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-94.25%	—
Current Drawdown Current decline from peak	-65.00%	-85.33%	+20.33%
Average Drawdown Average peak-to-trough decline	-54.84%	-70.85%	+16.01%
Ulcer Index Depth and duration of drawdowns from previous peaks	14.61%	10.17%	+4.44%

Volatility

BIOA vs. ORMP - Volatility Comparison

BioAge Labs, Inc (BIOA) has a higher volatility of 103.31% compared to Oramed Pharmaceuticals Inc. (ORMP) at 11.91%. This indicates that BIOA's price experiences larger fluctuations and is considered to be riskier than ORMP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BIOA	ORMP	Difference
Volatility (1M) Calculated over the trailing 1-month period	103.31%	11.91%	+91.40%
Volatility (6M) Calculated over the trailing 6-month period	113.94%	40.10%	+73.84%
Volatility (1Y) Calculated over the trailing 1-year period	106.51%	54.09%	+52.42%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	108.89%	80.52%	+28.37%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	108.89%	72.22%	+36.67%

Dividends

BIOA vs. ORMP - Dividend Comparison

BIOA has not paid dividends to shareholders, while ORMP's dividend yield for the trailing twelve months is around 6.14%.

Position	TTM
BIOA BioAge Labs, Inc	0.00%
ORMP Oramed Pharmaceuticals Inc.	6.14%

Financials

Frequently Asked Questions

Can I hold both BIOA and ORMP in my portfolio?

BIOA and ORMP have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, BIOA or ORMP?

BIOA has higher volatility (103.31%) compared to ORMP (11.91%). In terms of maximum drawdown, BIOA dropped -88.23% vs ORMP's -94.25%.

Which has better risk-adjusted returns?

ORMP currently has the higher Sharpe Ratio (1.92 vs 1.00), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.